In contrast to the earlier findings that GLP-2 increased aBMD in SBS patients (75), Gottschalck et al. reported that reductions in CTX after exogenous GLP-2 requires an intact small intestine, indicating an indirect effect of GLP-2 involving the intestine (77, 78). Here, GCG is linked to macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.